Research & Development

Can Roche's New Obesity Pill CT-996 Revolutionize Weight Loss?
Research & Development Can Roche's New Obesity Pill CT-996 Revolutionize Weight Loss?

The global obesity epidemic has led to an urgent demand for innovative and effective treatments. Traditional methods like diet, exercise, and surgical interventions present various challenges, often marked by inconsistent results and reduced patient compliance. In response, the pharmaceutical

How Will Cardurion's $260M Funding Transform Heart Disease Treatment?
Research & Development How Will Cardurion's $260M Funding Transform Heart Disease Treatment?

Cardurion Pharmaceuticals has recently made headlines by securing a $260 million Series B financing round. This substantial investment underscores the fierce commitment to advancing the treatment of heart disease, one of the leading causes of mortality worldwide. The funds raised will propel

Legend Biotech Buyout Speculation Raises Stakes in CAR-T Therapy Market
Research & Development Legend Biotech Buyout Speculation Raises Stakes in CAR-T Therapy Market

Legend Biotech, widely recognized for its collaboration with Johnson & Johnson (J&J) on the BCMA CAR-T therapy Carvykti, has found itself at the center of buyout speculation, which has reverberated across biotech markets. Reports of an acquisition bid prompted the company to engage Centerview

Can Pfizer and Evotec's Partnership Revolutionize Disease Therapies?
Research & Development Can Pfizer and Evotec's Partnership Revolutionize Disease Therapies?

In a groundbreaking partnership aimed at revolutionary advancements in biopharmaceutical research, Pfizer and Evotec have joined forces to discover new therapeutics targeting metabolic and infectious diseases. Announced on July 10, 2024, this collaboration will leverage Evotec’s state-of-the-art

Amylyx Shifts Focus to GLP-1 Drug Development After ALS Setback
Research & Development Amylyx Shifts Focus to GLP-1 Drug Development After ALS Setback

Amylyx Pharmaceuticals, a prominent Massachusetts-based biotech firm, is entering a new era marked by a strategic pivot toward the development of GLP-1-based drugs aimed at blood sugar regulation. This shift comes after a major setback with their ALS drug, AMX0035. The company now sets its sights

What Are the Key Drivers and Challenges in Pancreatic Cancer Growth?
Research & Development What Are the Key Drivers and Challenges in Pancreatic Cancer Growth?

Pancreatic cancer is a complex and aggressive disease that remains one of the deadliest forms of cancer. Its market, valued at approximately USD 1.6 billion in 2020 across the 7MM regions (the United States, the EU-4 [Italy, Spain, France, and Germany], the United Kingdom, and Japan), is poised for

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later